Fund shareholders of Capricor Therapeutics Inc
ISIN US14070B3096 · United States · LEI 5493002ZI5PDLXV4DX14
- Fund shareholders
- 131
- Of which ETFs
- 21 110 other funds
- Value held
- 248M $ 4.6M SEK
- Share of capital
- 14.1 % of 58.1M shares on Aug 13, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 1,414 | 43K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Longboard Fund NORTHERN LIGHTS FUND TRUST II | 1,359 | 38K $ | 0.04 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 1,100 | 33.4K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 1,099 | 33.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 1,083 | 36.4K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 1,035 | 31.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 886 | 26.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 797 | 22.3K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 787 | 23.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 722 | 21.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Putnam Dynamic Asset Allocation Conservative Fund Putnam Asset Allocation Funds | 670 | 20.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 491 | 16.5K $ | 0.03 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Hypatia Women CEO ETF Two Roads Shared Trust | 480 | 16.1K $ | 0.19 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Putnam Multi-Asset Income Fund Putnam Asset Allocation Funds | 405 | 11.3K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| SA Franklin Allocation Moderately Aggressive Portfolio SEASONS SERIES TRUST | 328 | 10K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 324 | 9.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 278 | 8.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Putnam VT Global Asset Allocation Fund Putnam Variable Trust | 216 | 6.6K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 196 | 6K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 187 | 5.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 146 | 4.4K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Innovator U.S. Small Cap Managed 10 Buffer ETF Innovator ETFs Trust | 135 | 4.5K $ | 0.06 % | 0.00 % | as of Apr 30, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 110 | 3.3K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 90 | 2.7K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 80 | 2.7K $ | 0.03 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 54 | 1.6K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 40 | 1.2K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 39 | 1.1K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 13 | 363.1 $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Flex Small Cap Focused Index Fund Fidelity Salem Street Trust | 10 | 335.8 $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 10 | 304 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Invesco Dorsey Wright Healthcare Momentum ETF Invesco Exchange-Traded Fund Trust | 2.26 % | as of Apr 30, 2026 ↗ |
| iShares Neuroscience and Healthcare ETF iShares Trust | 1.75 % | as of Apr 30, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 0.95 % | as of Apr 30, 2026 ↗ |
| Select Pharmaceuticals Portfolio Fidelity Select Portfolios | 0.72 % | as of Feb 28, 2026 ↗ |
| Dunham Small Cap Growth Fund Dunham Funds | 0.48 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 0.48 % | as of Mar 31, 2026 ↗ |
| PROFUND VP BIOTECHNOLOGY ProFunds | 0.47 % | as of Mar 31, 2026 ↗ |
| Direxion Daily S&P Biotech Bull 3X Shares Direxion Shares ETF Trust | 0.43 % | as of Apr 30, 2026 ↗ |
| BIOTECHNOLOGY ULTRASECTOR PROFUND ProFunds | 0.38 % | as of Apr 30, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.28 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 130 | +27 | 8,176,255 | +53.0 % |
| 2026Q1 | 103 | +5 | 5,344,310 | +4.7 % |
| 2025Q4 | 98 | -8 | 5,104,633 | -16.6 % |
| 2025Q3 | 106 | -5 | 6,119,356 | -4.0 % |
| 2025Q2 | 111 | +14 | 6,374,773 | +0.8 % |
| 2025Q1 | 97 | +22 | 6,327,231 | +83.4 % |
| 2024Q4 | 75 | +41 | 3,449,184 | +59.6 % |
| 2024Q3 | 34 | +20 | 2,161,681 | +25.3 % |
| 2024Q2 | 14 | +1 | 1,725,297 | +16.0 % |
| 2024Q1 | 13 | -3 | 1,487,767 | -2.8 % |
| 2023Q4 | 16 | 1,530,235 |
Institutional managers
170 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,818,600 | 116.1M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 3,421,815 | 104M $ | as of Mar 31, 2026 |
| TANG CAPITAL MANAGEMENT LLC | 3,399,900 | 103.4M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 2,181,901 | 66.3M $ | as of Mar 31, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | 1,507,844 | 45.8M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,118,326 | 34M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 911,976 | 27.7M $ | as of Mar 31, 2026 |
| Jones Hill Capital LP | 909,207 | 27.6M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 821,179 | 25M $ | as of Mar 31, 2026 |
| FMR LLC | 772,649 | 23.5M $ | as of Mar 31, 2026 |
| Boxer Capital Management, LLC | 590,000 | 17.9M $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 566,081 | 17.2M $ | as of Mar 31, 2026 |
| J. Goldman & Co LP | 541,522 | 16.5M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 539,232 | 16.4M $ | as of Mar 31, 2026 |
| Ikarian Capital, LLC | 528,015 | 16.1M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 423,819 | 12.9M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 417,543 | 12.7M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 415,483 | 12.6M $ | as of Mar 31, 2026 |
| MERCER GLOBAL ADVISORS INC /ADV | 402,999 | 12.3M $ | as of Mar 31, 2026 |
| DG Capital Management, LLC | 392,096 | 11.9M $ | as of Mar 31, 2026 |
| UBS Group AG | 371,984 | 11.3M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 356,354 | 10.8M $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 343,613 | 9.5M $ | as of Mar 31, 2026 |
| BARCLAYS PLC | 314,792 | 9.6M $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 297,123 | 9M $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Fund shareholders of Capricor Therapeutics Inc". https://titelia.com/en/stocks/capricor-therapeutics-inc-US14070B3096